Literature DB >> 33505301

Propionate and Alzheimer's Disease.

Jessica Killingsworth1, Darrell Sawmiller1, R Douglas Shytle1.   

Abstract

Propionate, a short-chain fatty acid, serves important roles in the human body. However, our review of the current literature suggests that under certain conditions, excess levels of propionate may play a role in Alzheimer's disease (AD). The cause of the excessive levels of propionate may be related to the Bacteroidetes phylum, which are the primary producers of propionate in the human gut. Studies have shown that the relative abundance of the Bacteroidetes phylum is significantly increased in older adults. Other studies have shown that levels of the Bacteroidetes phylum are increased in persons with AD. Studies on the diet, medication use, and propionate metabolism offer additional potential causes. There are many different mechanisms by which excess levels of propionate may lead to AD, such as hyperammonemia. These mechanisms offer potential points for intervention.
Copyright © 2021 Killingsworth, Sawmiller and Shytle.

Entities:  

Keywords:  Alzheimer’s disease; gut microbiome; propionate; short chain fatty acids; valproate

Year:  2021        PMID: 33505301      PMCID: PMC7831739          DOI: 10.3389/fnagi.2020.580001

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


  125 in total

1.  THE PATHOGENIC ROLE OF CORYNEBACTERIUM ACNES IN ACNE VULGARIS.

Authors:  J O KIRSCHBAUM; A M KLIGMAN
Journal:  Arch Dermatol       Date:  1963-12

2.  Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder.

Authors:  Lv Wang; Claus Thagaard Christophersen; Michael Joseph Sorich; Jacobus Petrus Gerber; Manya Therese Angley; Michael Allan Conlon
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

3.  Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.

Authors:  Pravat K Mandal; Sumiti Saharan; Manjari Tripathi; Geetanjali Murari
Journal:  Biol Psychiatry       Date:  2015-04-14       Impact factor: 13.382

4.  Transcellular traversal of the blood-brain barrier by the pathogenic Propionibacterium acnes.

Authors:  Xuetao Lu; Xianlong Qi; Xiuli Yi; Zhe Jian; Tianwen Gao
Journal:  J Cell Biochem       Date:  2018-11-28       Impact factor: 4.429

5.  2020 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2020-03-10       Impact factor: 21.566

6.  Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1.

Authors:  Jiaming Liu; Fangyan Wang; Suzhi Liu; Jimei Du; Xuezhen Hu; Jiaojiao Xiong; Renchi Fang; Wenqian Chen; Jing Sun
Journal:  J Neurol Sci       Date:  2017-08-24       Impact factor: 3.181

Review 7.  Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.

Authors:  Chi-Tso Chiu; Zhifei Wang; Joshua G Hunsberger; De-Maw Chuang
Journal:  Pharmacol Rev       Date:  2013-01-08       Impact factor: 25.468

8.  Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid.

Authors:  Masazumi Ando; Hideaki Amayasu; Takahiro Itai; Hisahiro Yoshida
Journal:  Biopsychosoc Med       Date:  2017-07-05

9.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

10.  Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial.

Authors:  Edward S Chambers; Claire S Byrne; Douglas J Morrison; Kevin G Murphy; Tom Preston; Catriona Tedford; Isabel Garcia-Perez; Sofia Fountana; Jose Ivan Serrano-Contreras; Elaine Holmes; Catherine J Reynolds; Jordie F Roberts; Rosemary J Boyton; Daniel M Altmann; Julie A K McDonald; Julian R Marchesi; Arne N Akbar; Natalie E Riddell; Gareth A Wallis; Gary S Frost
Journal:  Gut       Date:  2019-04-10       Impact factor: 23.059

View more
  6 in total

1.  Assessing the joint effects of brain aging and gut microbiota on the risks of psychiatric disorders.

Authors:  Huijie Zhang; Li Liu; Shiqiang Cheng; Yumeng Jia; Yan Wen; Xuena Yang; Peilin Meng; Chun'e Li; Chuyu Pan; Yujing Chen; Zhen Zhang; Jingxi Zhang; Feng Zhang
Journal:  Brain Imaging Behav       Date:  2022-01-25       Impact factor: 3.224

2.  The Relationship between Gut Microbiome and Cognition in Older Australians.

Authors:  Mrudhula Komanduri; Karen Savage; Ana Lea; Grace McPhee; Karen Nolidin; Saurenne Deleuil; Con Stough; Shakuntla Gondalia
Journal:  Nutrients       Date:  2021-12-24       Impact factor: 5.717

3.  Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis.

Authors:  Abdulahad Bayraktar; Simon Lam; Ozlem Altay; Xiangyu Li; Meng Yuan; Cheng Zhang; Muhammad Arif; Hasan Turkez; Mathias Uhlén; Saeed Shoaie; Adil Mardinoglu
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

4.  Axillary Microbiota Is Associated with Cognitive Impairment in Parkinson's Disease Patients.

Authors:  Muzaffer Arikan; Zeynep Yildiz; Tugce Kahraman Demir; Nesrin H Yilmaz; Aysu Sen; Lutfu Hanoglu; Suleyman Yildirim
Journal:  Microbiol Spectr       Date:  2022-02-09

Review 5.  A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia.

Authors:  A J McGuinness; J A Davis; S L Dawson; A Loughman; F Collier; M O'Hely; C A Simpson; J Green; W Marx; C Hair; G Guest; M Mohebbi; M Berk; D Stupart; D Watters; F N Jacka
Journal:  Mol Psychiatry       Date:  2022-02-22       Impact factor: 13.437

6.  Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota.

Authors:  Jiale Wang; Xiaoting Zhu; Yuhui Li; Wenping Guo; Mingquan Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-31       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.